Results 1 to 10 of about 1,047 (134)

Recurrent tumefactive demyelinating lesions in an elderly woman [PDF]

open access: yesRadiology Case Reports, 2022
Here we describe a 72-year old Caucasian woman who presented with progressive left hemiparesis and hemisensory deficits due to a pathology-confirmed tumefactive demyelinating lesion in the right frontoparietal region.
Erika L. Weil, MD   +1 more
doaj   +4 more sources

Silent Tumefactive Demyelinating Lesions and Radiologically Isolated Syndrome [PDF]

open access: yesCase Reports in Neurological Medicine, 2018
Demyelinating lesions larger than 2 cm in diameter, with or without edema, are known as tumefactive demyelinating lesions (TDLs). They constitute a rare inflammatory demyelinating disorder of the central nervous system.
Ozgul Ekmekci, Cenk Eraslan
doaj   +5 more sources

Phenotyping variants of tumefactive demyelinating lesions according to clinical and radiological features—A case series [PDF]

open access: yesFrontiers in Neurology, 2023
BackgroundTumefactive demyelinating lesions (TDLs) are defined as lesions >2 cm on MRI of the brain. They are identified in a range of demyelinating diseases including massive demyelination due to Marburg's acute MS, Schilder's Disease, Balo's ...
Thérèse Boyle   +11 more
doaj   +2 more sources

Immunopathology of Tumefactive Demyelinating Lesions-From Idiopathic to Drug-Related Cases [PDF]

open access: yesFrontiers in Neurology, 2022
Tumefactive demyelinating lesions (TDL) represent a diagnostic dilemma for clinicians, and in rare atypical cases a collaboration of a neuroradiologist, a neurologist, and a neuropathologist is warranted for accurate diagnosis.
Aigli G. Vakrakou   +5 more
doaj   +2 more sources

Clinical spectrum and prognosis of pathologically confirmed atypical tumefactive demyelinating lesions [PDF]

open access: yesScientific Reports, 2023
To describe the clinical spectrum and prognosis of atypical tumefactive demyelinating lesions (TDLs), which were confirmed by pathology. A total of 11 patients were diagnosed with atypical TDLs confirmed by brain biopsy and surgery between January 2006 ...
Yajing Zhang   +10 more
doaj   +2 more sources

Central nervous system tumefactive demyelinating lesions: Risk factors of relapse and follow-up observations [PDF]

open access: yesFrontiers in Immunology, 2022
ObjectiveTo track the clinical outcomes in patients who initially presented with tumefactive demyelinating lesions (TDLs), we summarized the clinical characteristics of various etiologies, and identified possible relapse risk factors for TDLs ...
Xinnan Li   +9 more
doaj   +2 more sources

Cerebral tumefactive demyelinating lesions. [PDF]

open access: yesOncol Lett, 2015
Tumefactive demyelinating lesions (TDLs), are a rare demyelinating pathological disease in the central neurological system, which have been proven to be a diagnostic dilemma to neurosurgeons. The clinical presentation and radiographic appearance of these lesions often results in their misdiagnosis as intracranial tumors, such as gliomas, which leads to
Qi W, Jia GE, Wang X, Zhang M, Ma Z.
europepmc   +4 more sources

Neuroimaging features of tumefactive demyelinating lesions: A rare case report [PDF]

open access: yesEuropean Journal of Radiology Open, 2020
Tumefactive demyelinating lesion is a special type of neuro-inflammatory disease with unusual variants to be found in magnetic resonance imaging. It manifests as a solitary or multiple lesion greater than 2 cm in diameter and often clinically challenging
Febyan   +3 more
doaj   +2 more sources

Decisive role of brain biopsy in atypical tumefactive demyelinating lesions: A case report [PDF]

open access: yesRadiology Case Reports
In neuroimaging, tumefactive demyelinating lesions (TDLs), which are rare inflammatory lesions of the central nervous system, can sometimes resemble infectious or malignant processes. Radiologic distinction is frequently made more difficult by their huge
Nazlı Gamze Bülbül, MD   +8 more
doaj   +2 more sources

Neuroimaging and clinicopathological differences between tumefactive demyelinating lesions and sentinel lesions of primary central nervous system lymphoma [PDF]

open access: yesFrontiers in Immunology, 2022
ObjectiveIt is still a challenge to distinguish sentinel lesions of primary central nervous system lymphoma (PCNSL) from atypical tumefactive demyelinating lesions (TDLs) in clinical practice.
Chenjing Sun   +6 more
doaj   +2 more sources

Home - About - Disclaimer - Privacy